Pluristem Therapeutics Granted New Patent amid Positive Clinical Trial

Stem-Cell research company Pluristem Therapeutics Inc . 's share value has been rising steadily on a bevy of positive news the company has been releasing ranging from successful clinical trials to being granted new patents.

http://ift.tt/MgKxZc